- Home
- SVM vs DVAX Comparison
SVM vs DVAX Comparison
Compare SVM & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- DVAX
- Stock Information
- Founded
- SVM N/A
- DVAX 1996
- Country
- SVM Canada
- DVAX United States
- Employees
- SVM N/A
- DVAX N/A
- Industry
- SVM Precious Metals
- DVAX Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- DVAX Health Care
- Exchange
- SVM Nasdaq
- DVAX Nasdaq
- Market Cap
- SVM 1.4B
- DVAX 1.2B
- IPO Year
- SVM N/A
- DVAX 2004
- Fundamental
- Price
- SVM $6.39
- DVAX $10.40
- Analyst Decision
- SVM Strong Buy
- DVAX Buy
- Analyst Count
- SVM 1
- DVAX 4
- Target Price
- SVM $6.75
- DVAX $26.50
- AVG Volume (30 Days)
- SVM 7.6M
- DVAX 1.3M
- Earning Date
- SVM 11-06-2025
- DVAX 11-05-2025
- Dividend Yield
- SVM 0.39%
- DVAX N/A
- EPS Growth
- SVM N/A
- DVAX N/A
- EPS
- SVM 0.25
- DVAX N/A
- Revenue
- SVM $308,064,000.00
- DVAX $316,268,000.00
- Revenue This Year
- SVM $10.42
- DVAX $23.23
- Revenue Next Year
- SVM $39.88
- DVAX $16.57
- P/E Ratio
- SVM $25.77
- DVAX N/A
- Revenue Growth
- SVM 35.50
- DVAX 26.66
- 52 Week Low
- SVM $2.87
- DVAX $9.20
- 52 Week High
- SVM $7.78
- DVAX $14.63
- Technical
- Relative Strength Index (RSI)
- SVM 49.97
- DVAX 58.69
- Support Level
- SVM $6.10
- DVAX $10.03
- Resistance Level
- SVM $6.65
- DVAX $10.12
- Average True Range (ATR)
- SVM 0.39
- DVAX 0.22
- MACD
- SVM -0.15
- DVAX 0.05
- Stochastic Oscillator
- SVM 18.45
- DVAX 99.25
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.